sars cov 1 spike Search Results


N/A
HEK293T Cell Line Stable Expressing SARS-CoV-1 Spike
  Buy from Supplier

94
Cell Signaling Technology Inc mouse mab
Mouse Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/SARS-CoV-1%2F2+Spike+Protein+Mouse+mAb/pm37627407-110-38-41
Average 94 stars, based on 1 article reviews
mouse mab - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

92
Cell Signaling Technology Inc rabbit monoclonal antibody
Rabbit Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/SARS-CoV-1+Spike+Protein+Rabbit+mAb/pmc09039667-111-15-25
Average 92 stars, based on 1 article reviews
rabbit monoclonal antibody - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

93
BPS Bioscience cmv promoter
Cmv Promoter, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/Spike+(SARS-CoV-1)+Pseudotyped+Lentivirus/pmc11277692-217-11-13
Average 93 stars, based on 1 article reviews
cmv promoter - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
ProSci Incorporated recombinant spike protein sars cov spike protein
The MBs-based assay <t>for</t> <t>SARS-CoV-2</t> detection in untreated saliva.
Recombinant Spike Protein Sars Cov Spike Protein, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/SARS-CoV-1+Pseudovirus/pmc07833515-157-62-45
Average 90 stars, based on 1 article reviews
recombinant spike protein sars cov spike protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

94
BPS Bioscience s ace2 interaction
The MBs-based assay <t>for</t> <t>SARS-CoV-2</t> detection in untreated saliva.
S Ace2 Interaction, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/SARS-CoV-1+Spike+Trimer+(S1%2BS2)%3AACE2+Inhibitor+Screening+Colorimetric+Assay+Kit/10__1021_slash_acsomega__4c10519-179-12-14
Average 94 stars, based on 1 article reviews
s ace2 interaction - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

91
BPS Bioscience spike protein
The MBs-based assay <t>for</t> <t>SARS-CoV-2</t> detection in untreated saliva.
Spike Protein, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/Spike+Trimer+(S1%2BS2)%2C+His-tag+(SARS-CoV-1)+Recombinant/pmc08287928-36-3-12
Average 91 stars, based on 1 article reviews
spike protein - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

90
GenScript corporation recombinant trimeric spike of sars-cov-1 spike-his-strep-flag
The MBs-based assay <t>for</t> <t>SARS-CoV-2</t> detection in untreated saliva.
Recombinant Trimeric Spike Of Sars Cov 1 Spike His Strep Flag, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/recombinant+trimeric+spike+of+sars+cov+1+spike+his+strep+flag/bio_rxiv__2024__11__07__622402-150-9-28
Average 90 stars, based on 1 article reviews
recombinant trimeric spike of sars-cov-1 spike-his-strep-flag - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioNTech 3d structures of the sars-cov-1 spike protein

3d Structures Of The Sars Cov 1 Spike Protein, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+1+spike/3d+structures+of+the+sars+cov+1+spike+protein/pmc08567414-131-26-7
Average 90 stars, based on 1 article reviews
3d structures of the sars-cov-1 spike protein - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

N/A
Severe acute respiratory syndrome (SARS) was the first new infectious disease identified in the twenty-first century. It is a viral respiratory disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-1). The first known cases occurred
  Buy from Supplier

N/A
SARS CoV 1 monoclonal Spike S1 VHH neutralizing antibody a a 1 127 full length with C terminal Avi Tag fused to the Fc portion of Human IgG1 expressed in a HEK293 cell expression system
  Buy from Supplier

Image Search Results


The MBs-based assay for SARS-CoV-2 detection in untreated saliva.

Journal: Biosensors & Bioelectronics

Article Title: Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva

doi: 10.1016/j.bios.2020.112686

Figure Lengend Snippet: The MBs-based assay for SARS-CoV-2 detection in untreated saliva.

Article Snippet: The use of the high sensitive antibodies is one of the main task to develop high sensitive and selective analytical device, thus for the selection of antibodies, spectrophotometric ELISA was carried out to assess the reactivity of MAb and two different PAb (Sinobiological, Germany and ProSci, USA) towards two different S proteins namely SARS Coronavirus 2019 Spike Recombinant protein (1000–1200 aa) and Recombinant Spike protein SARS-CoV Spike protein, S1 subunit.

Techniques:

A) ELISA response for two different PAb anti-SARS-CoV-2 1 μg/mL (Sinobiological and ProSci) towards two different Spike proteins coated at 2 ng/mL. B) Binding curve of colorimetric ELISA for MAb anti-SARS-CoV-2 ranging from 0.12 – 2 μg/mL. Coating of Spike protein: 2 ng/mL. C) Electrochemical response using the MBs-based assay using CB-based modified electrode (blue line) and bare electrode (black line). The mean value (n = 3) with the corresponding standard deviation was reported for each measurement. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Biosensors & Bioelectronics

Article Title: Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva

doi: 10.1016/j.bios.2020.112686

Figure Lengend Snippet: A) ELISA response for two different PAb anti-SARS-CoV-2 1 μg/mL (Sinobiological and ProSci) towards two different Spike proteins coated at 2 ng/mL. B) Binding curve of colorimetric ELISA for MAb anti-SARS-CoV-2 ranging from 0.12 – 2 μg/mL. Coating of Spike protein: 2 ng/mL. C) Electrochemical response using the MBs-based assay using CB-based modified electrode (blue line) and bare electrode (black line). The mean value (n = 3) with the corresponding standard deviation was reported for each measurement. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: The use of the high sensitive antibodies is one of the main task to develop high sensitive and selective analytical device, thus for the selection of antibodies, spectrophotometric ELISA was carried out to assess the reactivity of MAb and two different PAb (Sinobiological, Germany and ProSci, USA) towards two different S proteins namely SARS Coronavirus 2019 Spike Recombinant protein (1000–1200 aa) and Recombinant Spike protein SARS-CoV Spike protein, S1 subunit.

Techniques: Enzyme-linked Immunosorbent Assay, Binding Assay, Modification, Standard Deviation

A) Study of the signal response for evaluating PAb concentration. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 0.5, 1, and 2 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 0.5, 1, and 2 μg/mL (in PBS) + 300 μL of tested sample, incubation time 30 min without stirring, 3 washing steps, testing a negative control and 0.16 μg/mL of S protein. B) Study of the signal response for evaluating the effect of incubation time. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 1 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 1 μg/mL (in PBS) + 300 μL of tested sample, incubation time (15/30 min) without stirring, 3 washing steps, testing a negative control, 0.16 and 2.5 μg/mL of S protein. C) Study of the signal response as function of mixing during the incubation step. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 1 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 1 μg/mL (in PBS) + 300 μL of tested sample, incubation time 30 min with and without stirring, 3 washing steps, testing a negative control and 0.16 and 2.5 μg/mL of S protein. D) Study of the signal response for evaluating the effect of number of washing steps. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 1 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 1 μg/mL (in PBS) + 300 μL of tested sample, incubation time 30 min without stirring, 1/2/3 washing steps, testing a negative control and 0.16 μg/mL of S protein. The mean value (n = 3) with the corresponding standard deviation was reported for each measurement.

Journal: Biosensors & Bioelectronics

Article Title: Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva

doi: 10.1016/j.bios.2020.112686

Figure Lengend Snippet: A) Study of the signal response for evaluating PAb concentration. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 0.5, 1, and 2 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 0.5, 1, and 2 μg/mL (in PBS) + 300 μL of tested sample, incubation time 30 min without stirring, 3 washing steps, testing a negative control and 0.16 μg/mL of S protein. B) Study of the signal response for evaluating the effect of incubation time. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 1 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 1 μg/mL (in PBS) + 300 μL of tested sample, incubation time (15/30 min) without stirring, 3 washing steps, testing a negative control, 0.16 and 2.5 μg/mL of S protein. C) Study of the signal response as function of mixing during the incubation step. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 1 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 1 μg/mL (in PBS) + 300 μL of tested sample, incubation time 30 min with and without stirring, 3 washing steps, testing a negative control and 0.16 and 2.5 μg/mL of S protein. D) Study of the signal response for evaluating the effect of number of washing steps. 10 μL of MBs, 200 μL of PAb anti SARS-CoV-2 1 μg/mL (in PBS) + 200 μL of PAb-AP anti rabbit IgG 1 μg/mL (in PBS) + 300 μL of tested sample, incubation time 30 min without stirring, 1/2/3 washing steps, testing a negative control and 0.16 μg/mL of S protein. The mean value (n = 3) with the corresponding standard deviation was reported for each measurement.

Article Snippet: The use of the high sensitive antibodies is one of the main task to develop high sensitive and selective analytical device, thus for the selection of antibodies, spectrophotometric ELISA was carried out to assess the reactivity of MAb and two different PAb (Sinobiological, Germany and ProSci, USA) towards two different S proteins namely SARS Coronavirus 2019 Spike Recombinant protein (1000–1200 aa) and Recombinant Spike protein SARS-CoV Spike protein, S1 subunit.

Techniques: Concentration Assay, Incubation, Negative Control, Standard Deviation

A) Electrochemical calibration curve (inset the voltammograms) using the optimized parameters for S protein detection in buffer (black line) and in untreated saliva (red line) (n = 3). B) Electrochemical calibration curve (inset the voltammograms) for N protein detection in buffer (black line) and untreated saliva (red line) (n = 3). C) Voltammograms obtained without (black line) and with (blue line) cultured SARS-CoV-2 virus at concentration 6.5 PFU/mL using MBs-based immunoassay for S protein. D) Voltammograms obtained without (black line) and with (blue line) cultured SARS-CoV-2 virus at concentration 6.5 x 10 4 PFU/mL using MBs-based immunoassay for N protein. E) Exclusivity test on seasonal influenza virus A (H1N1) (10 2.9 TCID50 mL −1 ) and Influenza 2009 pH1N1 virus (10 4.15 TCID50 mL −1 ) in comparison to SARS-CoV-2 (6.5 PFU/mL) using assay for S protein (n = 3). F) Exclusivity test on seasonal influenza virus A (H1N1) (10 2.9 TCID50 mL −1 ) and 2009 influenza virus pH1N1 (10 4.15 TCID50 mL −1 ) in comparison to SARS-CoV-2 (6.5 x 10 4 PFU/mL) using assay for N protein (n = 3). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Biosensors & Bioelectronics

Article Title: Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva

doi: 10.1016/j.bios.2020.112686

Figure Lengend Snippet: A) Electrochemical calibration curve (inset the voltammograms) using the optimized parameters for S protein detection in buffer (black line) and in untreated saliva (red line) (n = 3). B) Electrochemical calibration curve (inset the voltammograms) for N protein detection in buffer (black line) and untreated saliva (red line) (n = 3). C) Voltammograms obtained without (black line) and with (blue line) cultured SARS-CoV-2 virus at concentration 6.5 PFU/mL using MBs-based immunoassay for S protein. D) Voltammograms obtained without (black line) and with (blue line) cultured SARS-CoV-2 virus at concentration 6.5 x 10 4 PFU/mL using MBs-based immunoassay for N protein. E) Exclusivity test on seasonal influenza virus A (H1N1) (10 2.9 TCID50 mL −1 ) and Influenza 2009 pH1N1 virus (10 4.15 TCID50 mL −1 ) in comparison to SARS-CoV-2 (6.5 PFU/mL) using assay for S protein (n = 3). F) Exclusivity test on seasonal influenza virus A (H1N1) (10 2.9 TCID50 mL −1 ) and 2009 influenza virus pH1N1 (10 4.15 TCID50 mL −1 ) in comparison to SARS-CoV-2 (6.5 x 10 4 PFU/mL) using assay for N protein (n = 3). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: The use of the high sensitive antibodies is one of the main task to develop high sensitive and selective analytical device, thus for the selection of antibodies, spectrophotometric ELISA was carried out to assess the reactivity of MAb and two different PAb (Sinobiological, Germany and ProSci, USA) towards two different S proteins namely SARS Coronavirus 2019 Spike Recombinant protein (1000–1200 aa) and Recombinant Spike protein SARS-CoV Spike protein, S1 subunit.

Techniques: Cell Culture, Concentration Assay

Overview of biosensors for  SARS-CoV-2  detection.

Journal: Biosensors & Bioelectronics

Article Title: Magnetic beads combined with carbon black-based screen-printed electrodes for COVID-19: A reliable and miniaturized electrochemical immunosensor for SARS-CoV-2 detection in saliva

doi: 10.1016/j.bios.2020.112686

Figure Lengend Snippet: Overview of biosensors for SARS-CoV-2 detection.

Article Snippet: The use of the high sensitive antibodies is one of the main task to develop high sensitive and selective analytical device, thus for the selection of antibodies, spectrophotometric ELISA was carried out to assess the reactivity of MAb and two different PAb (Sinobiological, Germany and ProSci, USA) towards two different S proteins namely SARS Coronavirus 2019 Spike Recombinant protein (1000–1200 aa) and Recombinant Spike protein SARS-CoV Spike protein, S1 subunit.

Techniques: CRISPR, Amplification, Reporter Assay, SPR Assay, Transduction, Fluorescence, Immunochromatographic Assay

Journal: Structure (London, England : 1993)

Article Title: RCSB Protein Data Bank resources for structure-facilitated design of mRNA vaccines for existing and emerging viral pathogens

doi: 10.1016/j.str.2021.10.008

Figure Lengend Snippet:

Article Snippet: During the design phase, researchers at both Pfizer-BioNTech and Moderna had open access to a total of 18 3D structures of the extracellular portion of the SARS-CoV-1 spike protein (first PDB: 5x5b , publicly released 5/3/2017; ).

Techniques: Software